Correlation Between Merck and INGEVITY

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and INGEVITY at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and INGEVITY into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and INGEVITY P 3875, you can compare the effects of market volatilities on Merck and INGEVITY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of INGEVITY. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and INGEVITY.

Diversification Opportunities for Merck and INGEVITY

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Merck and INGEVITY is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and INGEVITY P 3875 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INGEVITY P 3875 and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with INGEVITY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INGEVITY P 3875 has no effect on the direction of Merck i.e., Merck and INGEVITY go up and down completely randomly.

Pair Corralation between Merck and INGEVITY

Considering the 90-day investment horizon Merck Company is expected to under-perform the INGEVITY. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 38.33 times less risky than INGEVITY. The stock trades about 0.0 of its potential returns per unit of risk. The INGEVITY P 3875 is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  8,574  in INGEVITY P 3875 on August 24, 2024 and sell it today you would lose (43.00) from holding INGEVITY P 3875 or give up 0.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy88.91%
ValuesDaily Returns

Merck Company  vs.  INGEVITY P 3875

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
INGEVITY P 3875 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INGEVITY P 3875 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for INGEVITY P 3875 investors.

Merck and INGEVITY Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and INGEVITY

The main advantage of trading using opposite Merck and INGEVITY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, INGEVITY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INGEVITY will offset losses from the drop in INGEVITY's long position.
The idea behind Merck Company and INGEVITY P 3875 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities